Table 1.

Demographic and clinical investigations of the sample set.

				P value
	BA (n=53)	NHS (n=28)	HC (n=6)	BA vs HC	NHS vs HC	BA vs NHS
Age (days)	67 (32–145)	63 (33–194)	46.5 (29–113)	0.135	0.392	0.111
Gender (F/M)	16/37	9/19	2/4	0.874	0.890	0.856
Total Bilirubin (μmol/L)	156(80–271)	147 (43–419)	4.7 (4–14)	0.000	0.000	0.727
Direct Bilirubin (μmol/L)	113 (51–181)	99 (32–283)	1.6 (1–6)	0.000	0.000	0.109
Total Bile Acids (μmol/L)	117(34–282)	107 (24–320)	5.6 (3–11)	0.000	0.000	0.798
Alanine Aminotransferase (U/L)	126 (58–742)	111 (31–427)	25 (7–53)	0.000	0.000	0.153
Aspartate Aminotransferase (U/L)	231 (81–1440)	176 (61–651)	28 (9–59)	0.000	0.000	0.096
γ- Glutamyl Transferase (U/L)	670 (123–2074)	186 (41–815)	NA	NA	NA	0.001

BA, biliary atresia; NHS, neonatal hepatitis syndrome; HC, healthy control.